Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study

Pivonello, Rosario; Petersenn, Stephan; Newell-Price, John; Findling, James; Gu, Feng; Maldonado, Mario; Trovato, Andrew; Hughes, Gareth; Salgado, Luiz; Lacroix, Andre; Schopohl, Jochen; Biller, Beverly

doi:10.1111/cen.12431

Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study

Pivonello R., Petersenn S., Newell-Price J., Findling J. W., Gu F., Maldonado M., ...More

CLINICAL ENDOCRINOLOGY, vol.81, no.3, pp.408-417, 2014 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 81 Issue: 3
Publication Date: 2014
Doi Number: 10.1111/cen.12431
Journal Name: CLINICAL ENDOCRINOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.408-417
Istanbul University-Cerrahpasa Affiliated: No

Abstract

Objective Signs and symptoms of Cushing's disease are associated with high burden of illness. In this analysis, we evaluated the effect of pasireotide treatment on signs and symptoms in patients with Cushing's disease.